Literature DB >> 20106873

Defects in middle ear cavitation cause conductive hearing loss in the Tcof1 mutant mouse.

Carol A Richter1, Susan Amin, Jennifer Linden, Jill Dixon, Michael J Dixon, Abigail S Tucker.   

Abstract

Conductive hearing loss (CHL) is one of the most common forms of human deafness. Despite this observation, a surprising gap in our understanding of the mechanisms underlying CHL remains, particularly with respect to the molecular mechanisms underlying middle ear development and disease. Treacher Collins syndrome (TCS) is an autosomal dominant disorder of facial development that results from mutations in the gene TCOF1. CHL is a common feature of TCS but the causes of the hearing defect have not been studied. In this study, we have utilized Tcof1 mutant mice to dissect the developmental mechanisms underlying CHL. Our results demonstrate that effective cavitation of the middle ear is intimately linked to growth of the auditory bulla, the neural crest cell-derived structure that encapsulates all middle ear components, and that defects in these processes have a profoundly detrimental effect on hearing. This research provides important insights into a poorly characterized cause of human deafness, and provides the first mouse model for the study of middle ear cavity defects, while also being of direct relevance to a human genetic disorder.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20106873     DOI: 10.1093/hmg/ddq028

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  14 in total

Review 1.  The development of the mammalian outer and middle ear.

Authors:  Neal Anthwal; Hannah Thompson
Journal:  J Anat       Date:  2015-07-30       Impact factor: 2.610

2.  Genetic variation in thyroid folliculogenesis influences susceptibility to hypothyroidism-induced hearing impairment.

Authors:  Amanda H Mortensen; Qing Fang; Michelle T Fleming; Thomas J Jones; Alexandre Z Daly; Kenneth R Johnson; Sally A Camper
Journal:  Mamm Genome       Date:  2019-02-18       Impact factor: 2.957

Review 3.  Rare syndromes of the head and face: mandibulofacial and acrofacial dysostoses.

Authors:  Karla Terrazas; Jill Dixon; Paul A Trainor; Michael J Dixon
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2017-02-10       Impact factor: 5.814

4.  Identification of induced and naturally occurring conductive hearing loss in mice using bone conduction.

Authors:  David Chhan; Melissa L McKinnon; John J Rosowski
Journal:  Hear Res       Date:  2017-02-04       Impact factor: 3.208

5.  Thyroid hormone receptors control developmental maturation of the middle ear and the size of the ossicular bones.

Authors:  Emily A Cordas; Lily Ng; Arturo Hernandez; Masahiro Kaneshige; Sheue-Yann Cheng; Douglas Forrest
Journal:  Endocrinology       Date:  2012-01-17       Impact factor: 4.736

Review 6.  Neural crest contributions to the ear: Implications for congenital hearing disorders.

Authors:  K Elaine Ritter; Donna M Martin
Journal:  Hear Res       Date:  2018-11-14       Impact factor: 3.208

7.  A requirement for Fgfr2 in middle ear development.

Authors:  Diana Rigueur; Ryan R Roberts; Lauren Bobzin; Amy E Merrill
Journal:  Genesis       Date:  2018-10-04       Impact factor: 2.487

8.  A defect in early myogenesis causes Otitis media in two mouse models of 22q11.2 Deletion Syndrome.

Authors:  Jennifer C Fuchs; Jennifer F Linden; Antonio Baldini; Abigail S Tucker
Journal:  Hum Mol Genet       Date:  2014-12-01       Impact factor: 6.150

9.  Mapping the distribution of stem/progenitor cells across the mouse middle ear during homeostasis and inflammation.

Authors:  Abigail S Tucker; Carlene J Dyer; Juan M Fons Romero; Tathyane H N Teshima; Jennifer C Fuchs; Hannah Thompson
Journal:  Development       Date:  2018-01-11       Impact factor: 6.862

10.  Hearing loss in a mouse model of 22q11.2 Deletion Syndrome.

Authors:  Jennifer C Fuchs; Fhatarah A Zinnamon; Ruth R Taylor; Sarah Ivins; Peter J Scambler; Andrew Forge; Abigail S Tucker; Jennifer F Linden
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.